The Clear Reason Alkermes Plc's Shares Jumped by as Much as 12%
Shares of Alkermes (NASDAQ: ALKS), an Irish-based commercial-stage drug developer with a focus on central nervous system medicines, jumped by as much as 12% during Thursday's trading session and ultimately ended the day higher by 11%. The reason for the volatile day, which at one point saw Alkermes shares lower by 5%, was the release of its third-quarter operating results.
A topsy-turvy day for Alkermes was highlighted by an earnings report that seemed to head in opposite directions at times.
Image source: Getty Images.
Source: Fool.com
Alkermes plc Stock
€24.40
2.520%
With 17 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 35 € there is a positive potential of 43.44% for Alkermes plc compared to the current price of 24.4 €.
